| US FDA approved drugs from 2015–June 2020: a perspective P Bhutani, G Joshi, N Raja, N Bachhav, PK Rajanna, H Bhutani, AT Paul, ... Journal of Medicinal Chemistry 64 (5), 2339-2381, 2021 | 375 | 2021 |
| LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method H Bhutani, S Singh, S Vir, KK Bhutani, R Kumar, AK Chakraborti, ... Journal of pharmaceutical and biomedical analysis 43 (4), 1213-1220, 2007 | 127 | 2007 |
| Quality by design (QbD) in analytical sciences: an overview H Bhutani, M Kurmi, S Singh, S Beg, B Singh Quality Assurance 3, 39-45, 2004 | 106 | 2004 |
| Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs H Bhutani, S Singh, KC Jindal, AK Chakraborti Journal of pharmaceutical and biomedical analysis 39 (5), 892-899, 2005 | 74 | 2005 |
| ICH guidance in practice: validated stability-indicating HPLC method for simultaneous determination of ampicillin and cloxacillin in combination drug products V Kumar, H Bhutani, S Singh Journal of pharmaceutical and biomedical analysis 43 (2), 769-773, 2007 | 67 | 2007 |
| The physical and chemical stability of anti-tuberculosis fixed-dose combination products under accelerated climatic conditions H Bhutani, TT Mariappan, S Singh The International Journal of Tuberculosis and Lung Disease 8 (9), 1073-1080, 2004 | 61 | 2004 |
| Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light. 1. Pure anti … S Singh, H Bhutani, TT Mariappan, H Kaur, M Bajaj, SP Pakhale International journal of pharmaceutics 245 (1-2), 37-44, 2002 | 41 | 2002 |
| Drug-drug interaction studies on first-line anti-tuberculosis drugs H Bhutani, S Singh, KC Jindal Pharmaceutical development and technology 10 (4), 517-524, 2005 | 36 | 2005 |
| Behavior of moisture gain and equilibrium moisture contents (EMC) of various drug substances and correlation with compendial information on hygroscopicity and loss on drying NA Visalakshi, TT Mariappan, H Bhutani, S Singh Pharmaceutical development and technology 10 (4), 489-497, 2005 | 28 | 2005 |
| An explanation for the physical instability of a marketed fixed dose combination (FDC) formulation containing isoniazid and ethambutol and proposed solutions H Bhutani, TT Mariappan, S Singh Drug development and industrial pharmacy 30 (6), 667-672, 2004 | 28 | 2004 |
| Study of the interaction between rifapentine and isoniazid under acid conditions B Prasad, H Bhutani, S Singh Journal of pharmaceutical and biomedical analysis 41 (4), 1438-1441, 2006 | 27 | 2006 |
| Quality problems of anti-tuberculosis Fixed-dose Combinations (FDCS) A way forward. S Singh, H Bhutani, TT Mariappan | 25 | 2006 |
| Behavior of uptake of moisture by drugs and excipients under accelerated conditions of temperature and humidity in the absence and the presence of light-Part II: Packaged and … H Bhutani, TT Mariappan, S Singh Pharmaceutical Technology 27 (6), 44-44, 2003 | 24 | 2003 |
| Rapid and efficient chiral method development for lamivudine and tenofovir disoproxil fumarate fixed dose combination using ultra-high performance supercritical fluid … M Kurmi, K Jayaraman, S Natarajan, GS Kumar, H Bhutani, L Bajpai Journal of Chromatography A 1625, 461257, 2020 | 17 | 2020 |
| Cross-linking of poly (vinyl alcohol) films under acidic and thermal stress SD Desai, I Kundu, NP Swamy, GB Crull, D Pan, J Zhao, RP Shah, ... European Journal of Pharmaceutical Sciences 152, 105429, 2020 | 8 | 2020 |
| Supramolecular chemistry of BrettPhos and BrettPhos oxide: breakup of isostructurality via order–disorder phase transitions AG Dikundwar, P Chodon, SP Thomas, H Bhutani Crystal Growth & Design 17 (4), 1982-1990, 2017 | 8 | 2017 |
| Quantification of solid-state impurity with powder X-ray diffraction using laboratory source M Sundaram, S Natarajan, AG Dikundwar, H Bhutani Powder Diffraction 35 (4), 226-232, 2020 | 6 | 2020 |
| Development of HPLC-CAD stability indicating assay method for polyethylene glycol-conjugated phospholipid (DMPE-PEG 2000) and identification of its degradation products M Kurmi, V Suryavanshi, NS Panduranga, K Jayaraman, L Bajpai, W Fish, ... Journal of Pharmaceutical and Biomedical Analysis 198, 113967, 2021 | 5 | 2021 |
| Identification of extractables by liquid chromatography-high resolution mass spectrometry: A case study to understand the extraction profile of different disposable syringes M Kurmi, S Prasad, NS Panduranga, K Jayaraman, H Bhutani Journal of Pharmaceutical and Biomedical Analysis 191, 113602, 2020 | 5 | 2020 |
| Evaluation of derivative spectrophotometry for simultaneous determination of Ampicillin and Cloxacillin V Kumar, H Bhutani, S Singh INDIAN DRUGS-BOMBAY- 43 (5), 376, 2006 | 5 | 2006 |
